The Tech - Online EditionMIT's oldest and largest
newspaper & the first
newspaper published
on the web
Last Published: April 14, 2016
Boston Weather: 58.0°F | Partly Cloudy

Articles by Andrew Pollack

THE NEW YORK TIMES
October 3, 2014
U.S. federal officials are planning to sharply increase production of ZMapp, which is viewed by many experts as the most promising experimental drug for treating people stricken by Ebola in West Africa.
THE NEW YORK TIMES
September 5, 2014
The Food and Drug Administration on Thursday approved the first of an eagerly awaited new class of cancer drugs that unleash the body’s immune system to fight tumors.
THE NEW YORK TIMES
April 29, 2014
LOS ANGELES — The French pharmaceutical company Sanofi said Monday that its experimental vaccine for dengue fever had succeeded in its first late-stage clinical trial. The results could help pave the way for introduction of the first vaccine to prevent a disease that afflicts as many as 100 million people a year.
THE NEW YORK TIMES
December 6, 2013
Nelson Mandela, who led the emancipation of South Africa from white minority rule and served as his country’s first black president, becoming an international emblem of dignity and forbearance, died Thursday night. He was 95.
THE NEW YORK TIMES
December 6, 2013
For much of her adult life, Shirley Hickey received two injections a week in an effort to tame severe allergies that caused frequent sore throats and sinus infections. Now she uses a less painful method.
THE NEW YORK TIMES
September 24, 2013
Terri Ellsworth is convinced that her 12-year-old son Billy, who has Duchenne muscular dystrophy, is being helped by an experimental drug that counteracts the genetic mutation causing his disease.
THE NEW YORK TIMES
September 6, 2013
He was once hailed as the king of biotechnology. In the industry’s frontier days, David Blech was the top gunslinger, quick to draw his checkbook to start new companies or prop up faltering ones.
THE NEW YORK TIMES
April 26, 2013
With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual step of banding together in hopes of persuading some leading pharmaceutical companies to bring prices down.
THE NEW YORK TIMES
April 12, 2013
After a crash inspection program, federal regulators said Thursday that they had found numerous unsafe practices at about 30 compounding pharmacies, the same type of facility responsible for the tainted drug that caused a deadly meningitis outbreak last year.
THE NEW YORK TIMES
January 30, 2013
The Food and Drug Administration approved a new drug Tuesday that not only treats a rare inherited disorder that causes extremely high cholesterol levels and heart attacks by age 30 but does so using a long-sought technology that can shut off specific genes that cause disease.
<< First   1 | 2   Last >>